Products

Signal Tracker Data Platform Data Enrichment API Intelligence desk

Solutions

Inward Investment & Aftercare Deal Origination Executive Search Corporate Development Signal-Based Outbound Competitive Intelligence Funding Signals Competitor Monitoring For Sales Teams For Founders For Agencies For Investors

Explore

Companies Live Signals Markets Trends

Resources

Signal Checker Blog Integrations FAQ Contact Pricing
Login Book a demo
RNAimmune logo — Novel medicine for all through mRNA therapeutics.

RNAimmune

Novel medicine for all through mRNA therapeutics.

Founded 2020 United States Gaithersburg, United States 9 employees Series A Total: $39.35M Biotechnology, Health Care +1

General Information

Company Name RNAimmune
Founded Year 2020
Location United States Gaithersburg, United States +1
Employees 9
Industries Biotechnology, Health Care, Life Sciences
Funding Stage Series A
Social

Get notified when RNAimmune moves

Funding, new markets, leadership changes, hiring surges — one e-mail, only when something happens.

Free · no account needed

About RNAimmune

RNAimmune is a burgeoning player in the Biotechnology, Health Care, and Life Sciences industries, founded in 2020 with its headquarters in the United States. The company has established a compelling mission of delivering "Novel medicine for all through mRNA therapeutics." By leveraging cutting-edge mRNA technology, RNAimmune focuses on developing vaccines targeting cancer and respiratory viruses, highlighting its expertise in antigen engineering, targeted delivery, and novel lipid research.

In a significant stride towards growth, RNAimmune secured a $27.00M Series A investment on 29 March 2022. Key investors in this round include the Rotating Boulder Fund, Sirnaomics, and Smooth River, reflecting strong confidence from experienced stakeholders. As a young but ambitious enterprise, RNAimmune's collaborative approach positions it to revolutionize health care and address unmet medical needs on a global scale.

Services & Products

Development of mRNA-based vaccines
Cancer therapies
Antibody therapies
Treatment of rare diseases
Prophylactic vaccines
mRNA cancer immunotherapies
Research and development in mRNA design and delivery

Target Customers

Healthcare providers Pharmaceutical companies Biotech research institutions Regulatory bodies Patients in need of cancer and rare disease therapies

Funding Rounds & Investors (3)

View All
Funding Stage Amount Investors Lead Investors Date
Series A •••••• 2
Investor
•••• •••• 		01 Mar 2022
Seed •••••• 6
Investor
•••• •••• 		01 Apr 2021
Seed •••••• 1
Investor
01 Aug 2020

RNAimmune Alternatives & Competitors

View All Alternatives
RNAimmune vs
mCureX Therapeutics, Inc.
mCureX Therapeutics, Inc. Korea South

Pharmaceuticals, focuses on the research and development of mRNA (messenger RNA) vaccines and therap...

6 employees
Health Care, Health and Wellness
RNAimmune vs
Stemirna Therapeutics
Stemirna Therapeutics

Stemirna Therapeutics is a company centered on RNA technology for drug development, aiming to harnes...

Series D
4 employees
Biotechnology, Pharmaceutical
RNAimmune vs
Su Hui therapy
Su Hui therapy

Driving advancements in vaccine development, cell therapy, and mRNA drug innovation for a healthier...

Seed
Biotechnology
View all alternatives

FAQ About RNAimmune

Novel medicine for all through mRNA therapeutics.
RNAimmune was founded in 2020.
RNAimmune is headquartered in Gaithersburg, United States.
RNAimmune operates in the following industries: Biotechnology, Health Care, Life Sciences.
RNAimmune has approximately 9 employees.
RNAimmune has completed 3 funding rounds, raising a total of $39.35M. The latest funding stage is Series A.
RNAimmune offers: Development of mRNA-based vaccines, Cancer therapies, Antibody therapies, Treatment of rare diseases, Prophylactic vaccines, mRNA cancer immunotherapies, Research and development in mRNA design and delivery.
Top alternatives and competitors to RNAimmune include mCureX Therapeutics, Inc., Stemirna Therapeutics, Su Hui therapy, ANEMOCYTE , IMMORNA. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
RNAimmune and mCureX Therapeutics, Inc. are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Don't just browse. Track.

Signal Tracker monitors RNAimmune and millions of companies for funding rounds, hiring surges, product changes, and 40+ signal types — so you never miss an opportunity.

See how it works

One analytics cookie (Google Analytics). Cookie Policy